Øystein Rekdal
Chief Executive Officer at LYTIX BIOPHARMA
Net worth: 79 132 $ as of 2024-03-30
Profile
Øystein Rekdal is the founder of Lytix Biopharma AS, a company founded in 2003.
He holds the title of Chief Executive Officer at Lytix Biopharma AS starting in 2019.
Dr. Rekdal's current job is as a Professor at the University of Tromso.
He previously worked as a Director at Prophylix AS.
Dr. Rekdal obtained a doctorate degree from the University of Tromso.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LYTIX BIOPHARMA AS
0.35% | 2022-08-25 | 139,963 ( 0.35% ) | 79 132 $ | 2024-03-30 |
Øystein Rekdal active positions
| Companies | Position | Start |
|---|---|---|
| LYTIX BIOPHARMA | Chief Executive Officer | 2019-09-10 |
| University of Tromso | Corporate Officer/Principal | - |
Former positions of Øystein Rekdal
| Companies | Position | End |
|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Director/Board Member | - |
Training of Øystein Rekdal
| University of Tromso | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| Private companies | 1 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
- Stock Market
- Insiders
- Øystein Rekdal
